Treatment of HBV infection reduces the risk of hepatocellular carcinoma

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Gastroenterology & Hepatology | 2009年 / 6卷 / 1期
关键词：
D O I：
10.1038/ncpgasthep1304
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [41] The current state of the prevention of HBV infection, the carrier state and hepatocellular carcinoma
    Blumberg, BS
    [J]. RESEARCH IN VIROLOGY, 1997, 148 (02): : 91 - 94
  • [42] Liver resection for hepatocellular carcinoma based on HBV and HCV infection.
    Nakajima, Y
    Shimamura, T
    Haneda, T
    Nakanishi, K
    Tomioka, N
    Okubo, N
    Kimura, J
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A1272 - A1272
  • [43] A case of hepatocellular carcinoma in normal liver with no evidence of HBV or HCV infection
    Tanaka, T
    Hoshino, Y
    Hayashi, S
    Tanaka, S
    Tsuruta, K
    Okamoto, A
    Koike, M
    Hattori, N
    [J]. HEPATO-GASTROENTEROLOGY, 1996, 43 (11) : 1390 - 1394
  • [44] Influence of HBV genotype on the risk of hepatocellular carcinoma: mediating roles of different phase of viral infection and epigenetic modifications
    Wu, Wan-Jung
    Kuo, Yi-Chun
    Kao, Wei-Yi
    Yang, Shu-Han
    Wu, Chih-Feng
    Lin, Chih-Lin
    Liu, Chun-Jen
    Huang, Yi-Wen
    Yu, Ming-Whei
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E271 - E271
  • [45] ALCOHOL AND HBV INFECTION AS RISK-FACTORS FOR HEPATOCELLULAR-CARCINOMA IN ITALY - A MULTICENTRIC, CONTROLLED-STUDY
    PAGLIARO, L
    SIMONETTI, RG
    CRAXI, A
    SPANO, C
    FILIPPAZZO, MG
    PALAZZO, U
    PATTI, S
    GIANNUOLI, G
    MARRAFFA, A
    COLOMBO, M
    TOMMASINI, M
    BELLENTANI, S
    VILLA, E
    MANENTI, F
    CAPORASO, N
    COLTORTI, M
    DELVECCHIOBLANCO, C
    FARSI, P
    SMEDILE, A
    VERME, G
    [J]. HEPATO-GASTROENTEROLOGY, 1983, 30 (02) : 48 - 50
  • [46] Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection
    Ling Li
    Hie-Won Hann
    Shaogui Wan
    Richard S. Hann
    Chun Wang
    Yinzhi Lai
    Xishan Ye
    Alison Evans
    Ronald E. Myers
    Zhong Ye
    Bingshan Li
    Jinliang Xing
    Hushan Yang
    [J]. Scientific Reports, 6
  • [47] Cell-free circulating mitochondrial DNA content and risk of hepatocellular carcinoma in patients with chronic HBV infection
    Li, Ling
    Hann, Hie-Won
    Wan, Shaogui
    Hann, Richard S.
    Wang, Chun
    Lai, Yinzhi
    Ye, Xishan
    Evans, Alison
    Myers, Ronald E.
    Ye, Zhong
    Li, Bingshan
    Xing, Jinliang
    Yang, Hushan
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [48] Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk
    Liu, Shi
    Li, Yongyin
    Sun, Jian
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (15):
  • [49] Entecavir treatment significantly reduces the risk of hepatocellular carcinoma recurrence in patients with chronic hepatitis b
    Lee, Donghyeon
    Lee, Jeong-Hoon
    Cho, Yuri
    Lee, Yun Bin
    Kwon, Jung Hee
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    Kim, Chung Yong
    [J]. HEPATOLOGY, 2012, 56 : 371A - 371A
  • [50] Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma
    Mani, Saravana Kumar Kailasam
    Andrisani, Ourania
    [J]. CYTOKINE, 2019, 124
12345